contraindications to glp 1 agonist Independent Nurse - GLP-1 and GIP/GLP-1 receptor agonists for type 2 diabetes Clinical Focus on GLP-1 Agonists

Assuming that the hypoglycemic effect of this fraction resides in its ability to stimulate the endocrine pancreas to secrete insulin, the factor was named incretin [56,57]

More research is needed on the long-term impacts of switching from GLP-1s to phentermine

[DOI] [PubMed] [Google Scholar] 58

Glucagon is secreted by pancreatic cells when blood glucose is low and acts on liver to stimulate glycogenolysis, gluconeogenesis, and hepatic glucose output, thus raising glucose and preventing the sequelae of hypoglycemia

However, studies have shown that retinal layer thickness is significantly lower in pwIIH compared to healthy controls, meaning that axonal loss is more widespread than previously suspected, and also occurs in apparently effectively treated pwIIH and/or patients not reporting any visual disturbances at all [35]

Another plausible mechanistic explanation for a diminished incretin effect is the TCF7L2 -dependent repression of GLP-1R and GIPR expression on the -cells [569]